3,3-Difluoro-6-methylcyclooctyne

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氟化物
• 英文名称: 3,3-Difluoro-6-methylcyclooctyne
• 英文别名: 3,3-difluoro-6-methylcyclooctyne
• 化学式: C₉H₁₂F₂
• 分子量: 158.19
• InChiKey: ZVEUTGXKMMPBEL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• CHEMICAL CROSSLINKERS AND COMPOSITIONS THEREOF
  申请人：Nguyen Mark Quang

  公开号：US20140249319A1

  公开（公告）日：2014-09-04

  Chemical crosslinkers and methods of their synthesis are disclosed.

  化学交联剂及其合成方法已被披露。
• CLEAVABLE DRUG CONJUGATES, COMPOSITIONS THEREOF AND METHODS OF USE
  申请人：NGUYEN MARK QUANG

  公开号：US20140294851A1

  公开（公告）日：2014-10-02

  Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.

  揭示了一种含有易碱性交联剂的易碱性共轭物、其合成和使用方法。
• Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
  申请人：The General Hospital Corporation

  公开号：US20170362266A1

  公开（公告）日：2017-12-21

  The present application provides methods of functionalizing an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal or by culturing an organ or tissue in a bioreactor containing such nutrient. The present application also provides methods of selectively functionalizing extracellular matrix (ECM) of an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal. In some aspects, the present application provides a decellularized scaffold of a mammalian organ or tissue comprising an extracellular matrix, wherein the extracellular matrix of the decellularized scaffold is functionalized with a chemical group that is reactive in a bioorthogonal chemical reaction, such as an azide chemical group. The present application also provides biological prosthetic mesh and mammalian organs and tissues for transplantation prepared according to the methods of the application.

  本申请提供了一种通过向哺乳动物投与营养物质（例如，乙酰化N-叠氮基半乳糖氨酸Ac4GalNAz）或在含有这种营养物质的生物反应器中培养器官或组织来功能化哺乳动物器官或组织的方法。本申请还提供了一种通过向哺乳动物投与营养物质（例如，乙酰化N-叠氮基半乳糖氨酸Ac4GalNAz）来选择性地功能化哺乳动物器官或组织的细胞外基质（ECM）的方法。在某些方面，本申请提供了哺乳动物器官或组织的脱细胞支架，其中脱细胞支架的细胞外基质被功能化为在生物正交化学反应中具有反应性的化学基团，例如叠氮基团。本申请还提供了根据本申请的方法制备的生物义肢网和哺乳动物器官和组织用于移植。
• METHODS OF USING CLEAVABLE DRUG CONJUGATES AND COMPOSITIONS THEREOF
  申请人：Nguyen Mark Quang

  公开号：US20160143937A1

  公开（公告）日：2016-05-26

  Methods of synthesizing and using base-labile drug conjugates and compositions thereof are disclosed.

  本发明揭示了合成和使用碱性不稳定药物结合物及其组合物的方法。
• SYNTHESIS AND ISOLATION OF DENDRIMER BASED IMAGING SYSTEMS
  申请人：THE REGENTS OF THE UNIVERSITY OF MICHIGAN

  公开号：US20150352230A1

  公开（公告）日：2015-12-10

  The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).